Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Influenza polymerase basic protein 2 (PB2) is a subunit of the heterotrimeric RNA-dependent RNA polymerase complex (FluPol) essential for influenza virus replication and transcription. It binds to the 5' cap structure of host pre-mRNAs, enabling "cap-snatching" to prime viral mRNA synthesis. The residue at position 627 is a critical determinant for host range and pathogenicity. PB2 also plays a role in modulating the host immune response by targeting mitochondria.
Inhibition of viral RNA transcription and replication by blocking cap-snatching or disrupting polymerase complex formation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza Polymerase Basic Protein 2 (PB2).